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Abstract
The human mutilating disease chromoblastomycosis is caused by melanized members of
the order Chaetothyriales. To assess population diversity among 123 clinical strains of
agents of the disease in Brazil we applied sequencing of the rDNA internal transcribed
spacer region, and partial cell division cycle and β-tubulin genes. Strains studied were lim-
ited to three clusters divided over the single family Herpotrichiellaceae known to comprise
agents of the disease. A Fonsecaea cluster contained the most important agents, among
which F. pedrosoi was prevalent with 80% of the total set of strains, followed by 13% for F.
monophora, 3% for F. nubica, and a single isolate of F. pugnacius. Additional agents,
among which two novel species, were located among members of the genus Rhinocladiella
and Cyphellophora, with frequencies of 3% and 1%, respectively.
Author Summary
Chromoblastomycosis, a skin disease found among rural populations in tropical and sub-
tropical regions, is caused by melanized fungi related to the black yeasts. The present
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005102 November 28, 2016 1 / 20
a11111
OPENACCESS
Citation: Gomes RR, Vicente VA, Azevedo CMPSd,
Salgado CG, da Silva MB, Queiroz-Telles F, et al.
(2016) Molecular Epidemiology of Agents of
Human Chromoblastomycosis in Brazil with the
Description of Two Novel Species. PLoS Negl Trop
Dis 10(11): e0005102. doi:10.1371/journal.
pntd.0005102
Editor: Bodo Wanke, Fundac¸ão Oswaldo Cruz,
Brazil, BRAZIL
Received: June 19, 2016
Accepted: October 11, 2016
Published: November 28, 2016
Copyright: © 2016 Gomes et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files. Nomenclatural novelties and descriptions
were deposited in MycoBank (www.MycoBank.
org), accession number: MB 817305 and MB
817306. Sequence data are available in GenBank
(http://www.ncbi.nlm.nih.gov/genbank/), accession
numbers in Table 1.
Funding: This work was supported by Brazilian
government by financial support (Special Visiting
Researcher Project; grant number 059/2012PVE-
study evaluates the species distribution among 123 clinical strains from endemic areas in
Brazil based on multilocus sequence data, and describes two new agents of the disease
which proved to be affiliated to Rhinocladiella and Cyphellophora.
Introduction
Chromoblastomycosis is a chronic granulomatous infection of the skin caused by melanized
fungi. It has a worldwide distribution mainly in tropical and subtropical climate zones, with a
preference for humid climates with dense forestation, with Cladophialophora carrionii being
the only species that is restricted to semi-arid areas with Cactaceae as main vegetation.
Endemic areas are in Japan, Southeast Asia, Australia, Madagascar, as well as South and Cen-
tral America [1–7]. In Brazil, the infection is observed in all states, with an estimated preva-
lence of 1/196 thousand inhabitants, but in some hyperendemic regions a considerably higher
prevalence is noted [8]. Infection is assumed to occur through accidental inoculation of the
fungus via contaminated plant debris, being favored by agricultural activities denoting an
occupational nature of the disease. Chromoblastomycosis is one of the most frequent implan-
tation mycoses found among rural populations [2, 8–11].
Clinically, the disease is characterized by pseudoepitheliomatous hyperplasia with epider-
mal microabscesses and dermal granulomata [12, 13]. The disease has a slow evolution, but
finally may result in disfigurement of affected body sites [8]. The initial lesion is noted as a
small pink papule at the site of inoculation which gradually enlarges. Development of superfi-
cial erythematous plaques with scaly or warty appearance probably takes several months or
years. As a result of acanthosis these lesions may develop into large papillomatous and verru-
cous warts.
Species of the humid climate are particularly members of the genus Fonsecaea, with F. ped-
rosoi, F. monophora and F. nubica as prevalent agents [14–17]. Recently another species, F.
pugnacius was described [18]. Rhinocladiella aquaspersa is an uncommon species of humid as
well as of dry climates [19]. Other reported agents such as Phialophora verrucosa and Exophiala
dermatitidis [17, 20] are extremely rare and mostly cause other types of infections. Fonsecaea
pedrosoi is nearly exclusively isolated from chromoblastomycosis, while F. monophora repeat-
edly causes brain infection and F. pugnacius combines the two disorders by starting as chro-
moblastomycosis with cerebral dissemination in a single patient [18]. Species distinction of
agents of the disease is clinically significant because of the differences in prognosis of the
infection.
The present study evaluates the diversity of agents in endemic areas of Brazil based on mul-
tilocus sequence data, clinical aspects, direct mycological examination and culture. An enu-
meration of currently proven cases with molecular support in endemic areas in Brazil is
provided.
Results
A set of 123 clinical strains from cases of chromoblastomycosis from different endemic areas
in Brazil was analyzed. Judging from a reference set of partial LSU rDNA sequences of mem-
bers of Chaetothyriales available at CBS, agents of chromoblastomycosis were polyphyletic
within the order, being dispersed in three different clades: jeanselmei-, bantiana- and euro-
paea-clades (Fig 1, arrows).
Multilocus sequence analyses using ITS, and partial BT2 and CDC42 genes were performed
for identification and for elucidation of species identities (S1 Fig). The 123 clinical strains
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clustered in different clades within the Chaetothyriales, being centred around members of the
genera Fonsecaea, Rhinocladiella, and Cyphellophora (Table 1). The Brazilian clinical isolates
used in this study all were derived from humid climate zones; members of the Cladophialo-
phora carrionii group were not encountered.
Fonsecaea is nested in the ‘bantiana-clade’ (Table 1) and contains the prevalent agents of
the disease. Of the studied isolates, 98 (80%) grouped as Fonsecaea pedrosoi, followed by 16
(13%) isolates of F. monophora, 4 (3%) isolates of F. nubica and one isolate of F. pugnacius. Iso-
lates of the Rhinocladiella group and of phialophora-like species are considered as rare agents
of chromoblastomycosis in the Americas. Rhinocladiella was nested in the ‘jeanselmei-clade’
and the phialophora-like agent clustered in the ‘europaea-clade’ (presently known as Cyphello-
phoraceae); two unnamed species were uncovered (Fig 1).
The analyzed ITS and BT2 regions and a tree resulting from combined loci revealed identi-
cal topologies in phylogenetic analyses. The unnamed strains CMRP1287, CMRP1307,
IMT776 and CMRP1317 were found to be concordantly positioned in all trees and grouped
with remaining members of Rhinocladiella and Cyphellophora causing chromoblastomycosis
(Figs 2 and 3). Clinical strain CMRP1317 was located at a significant distance from all refer-
ence strains of Cyphellophora, i.e with combined ITS and BT2 data the distance was 23.4%.
Strains CMRP1287, CMRP1307 and IMT776 were also located at significant distance from
known species in Rhinocladiella (Table 2). Consequently the strains were judged to represent
novel taxa in Cyphellophora and Rhinocladiella, respectively.
We report the clinical cases caused by the novel Cyphellophora and Rhinocladiella species,
which are named below as C. ludoviensis and R. tropicalis, respectively. The species showed
optimal development at 30˚C and 27˚C, respectively, with a wide growth range between 18˚C
and 37˚C and with residual growth at 15˚C and 38˚C and maximum growth temperature at
37˚C; no growth was observed at 40˚C (Fig 4).
Cyphellophora ludoviensisC.M.P.S. Azevedo, R.R. Gomes, V.A. Vicente & de Hoog, sp.
nov. – MycoBank MB 817305 (Figs 2 and 5).
Etymology: named after the city where the case was first diagnosed, San Luis in Maranhão
State, Brazil.
Holotype: Maranhão State, Brazil, from skin lesion of human patient, dried holotype UPCB
85592 at Department of Botany Herbarium at Federal University of Parana´ (UPCB); type
strain CMRP1317 = LMICRO356 = CBM47. Additional information listed in Table 1.
Description of CMRP51317 after two weeks incubation on MEA at 28˚C: Colonies moder-
ately expanding, greyish olive to olivaceus black, with olivaceus black reverse. Hyphae pale oli-
vaceous brown, 1.2–6 μm wide, septate every 9–25 μm, occasionally bearing scarce phialides
and conidia. Phialides poorly differentiated, producing sub-spherical, hyaline conidia, 1.8
−2.5 μm. Creeping hyphae producing lateral outgrowths which become septate, pale brown
conidiophores 1.5−2.0 μm wide and with frequent anastomoses; chlamydospores developing
intercalarily or terminally on hyphae. Chlamydospores ovoidal, brown, 4.5−6.5 × 4.5 μm, with
irregularly thickened walls. Thickened terminal hyphae and spirally twisted hyphae frequently
present. Teleomorph unknown. Cardinal temperatures: minimum 18˚C, optimum 30˚C, max-
imum 37˚C, with residual growth at 15˚C and 38˚C.
Case report: Patient, a 57-year-old Caucasian male from Icatu, Brazil, was diagnosed in
2008 with lower limb injuries with nodular appearance and plaque. Moderate disease
Fig 1. Phylogeny of a representative selection of species in Chaetothyriales, based on confidently aligned LSU sequences. Constructed with
Maximum likelihood implemented in MEGA 7. Bootstrap values > 80% from 100 resampled datasets are shown with branches. Coloured boxes represent
species complexes taken from de Hoog et al. [21], Feng et al. [22], and Vicente et al. [23]. Clades with species causing chromoblastomycosis analysed in
this study are indicated with arrows. Type strain in bold.
doi:10.1371/journal.pntd.0005102.g001
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Table 1. Strains analysed.
Name Strain number Geograph/ Brazil Chromoblastomycose lesions ITS; BT2; CDC42; LSU
Fonsecaea monophora CMRP1290 MA, Northeast Polymorphic lesions KR732306; KR732312; KR732318
Fonsecaea monophora CMRP1329 PR, North Plaque KX434631; KX583711
Fonsecaea monophora CMRP1330 PR, North Nodular KX434632
Fonsecaea monophora CMRP1359 AM, North NI KX434633
Fonsecaea monophora CMRP1360 AM, North NI KX434634
Fonsecaea monophora CMRP1335 MG, Southeast NI KX434639
Fonsecaea monophora CMRP1366 PR, South Polymorphic lesions KX434635
Fonsecaea monophora CMRP1367 RS, South NI KX434636
Fonsecaea monophora CMRP1368 RS, South NI KX434637
Fonsecaea monophora CMRP1369 RS, South NI KX434638
Fonsecaea monophora CMRP1371 PR, South NI KX434640
Fonsecaea monophora CMRP1383 PR, South NI KX434641
Fonsecaea monophora CBS 102242 PR, South Verrucous EU938583; EU938549
Fonsecaea monophora CBS 102243 PR, South Scarring EU938579; EU938542
Fonsecaea monophora CBS 102246 PR, South NI AY366928; EU938543
Fonsecaea monophora CBS 102248 PR, South NI AY366926; EU938550
Fonsecaea nubica IAL 4004 BA, Northeast Verrucous KU892412
Fonsecaea nubica IAL 3994 RO, North Verrucous KU881739
Fonsecaea nubica IAL 3992 MG, Southeast Nodular and tumoral KU881735
Fonsecaea nubica IAL 3999 SP, Southeast Polymorphic lesions KU8811742
Fonsecaea pedrosoi CMRP1342 MA, Northeast NI KX434642
Fonsecaea pedrosoi CMRP1271 MA, Northeast Polymorphic lesions KR732301; KR732307; KR732313
Fonsecaea pedrosoi CMRP1272 MA, Northeast Nodular and plaque KR732302; KR732308; KR732314
Fonsecaea pedrosoi CMRP1273 MA, Northeast Plaque KR732303; KR732309; KR732315
Fonsecaea pedrosoi CMRP1274 MA, Northeast Nodular and plaque KR732304; KR732310; KR732316
Fonsecaea pedrosoi CMRP1275 MA, Northeast Plaque KR732305; KR732311; KR732317
Fonsecaea pedrosoi CMRP1276 MA, Northeast Scarring, nodular and plaque KX434643; -; KX583684
Fonsecaea pedrosoi CMRP1277 MA, Northeast Plaque KX434644; KX583712; KX583685
Fonsecaea pedrosoi CMRP1278 MA, Northeast Scarring and plaque KX434645; KX583713; KX583686
Fonsecaea pedrosoi CMRP1279 MA, Northeast Plaque KX434646; -; KX583687
Fonsecaea pedrosoi CMRP1280 MA, Northeast Nodular and plaque KX434647; KX583714; KX583688
Fonsecaea pedrosoi CMRP1281 MA, Northeast Nodular and plaque KX434648
Fonsecaea pedrosoi CMRP1282 MA, Northeast Nodular and plaque KX434649; -; KX583689
Fonsecaea pedrosoi CMRP1283 MA, Northeast Nodular and plaque KX434650; -; KX583690
Fonsecaea pedrosoi CMRP1284 MA, Northeast Plaque KX434651; KX583715; KX583691
Fonsecaea pedrosoi CMRP1285 MA, Northeast Plaque KX434652; -; KX583692
Fonsecaea pedrosoi CMRP1286 MA, Northeast Scarring, nodular and plaque KX434653; KX583716
Fonsecaea pedrosoi CMRP1288 MA, Northeast Scarring and plaque KX434654; KX583717; KX583693
Fonsecaea pedrosoi CMRP1289 MA, Northeast Plaque KX434655; -; KX583694
Name Strain number Geograph/ Brazil Chromoblastomycose lesions ITS; BT2; CDC42; LSU
Fonsecaea pedrosoi CMRP1291 MA, Northeast Plaque KX434656; KX583718; KX583695
Fonsecaea pedrosoi CMRP1292 MA, Northeast Plaque KX434657; KX583719; KX583696
Fonsecaea pedrosoi CMRP1293 MA, Northeast Plaque KX434658; KX583720; KX583697
Fonsecaea pedrosoi CMRP1294 MA, Northeast Scarring and plaque KX434659; KX583721; KX583698
Fonsecaea pedrosoi CMRP1295 MA, Northeast Scarring and plaque KX434660; -; KX583699
Fonsecaea pedrosoi CMRP1296 MA, Northeast Scarring, nodular and plaque KX434661; -; KX583700
Fonsecaea pedrosoi CMRP1298 MA, Northeast Plaque KX434662; KX583722
(Continued )
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Table 1. (Continued)
Fonsecaea pedrosoi CMRP1299 MA, Northeast Plaque KX434663; KX583723
Fonsecaea pedrosoi CMRP1300 MA, Northeast Scarring, nodular and plaque KX434664
Fonsecaea pedrosoi CMRP1301 MA, Northeast Plaque KX434665; KX583724; KX583701
Fonsecaea pedrosoi CMRP1302 MA, Northeast Scarring, nodular and plaque KX434666; KX583725; KX583702
Fonsecaea pedrosoi CMRP1303 MA, Northeast Plaque KX434667
Fonsecaea pedrosoi CMRP1304 MA, Northeast Polymorphic lesions KX434668; KX583726; KX583703
Fonsecaea pedrosoi CMRP1305 MA, Northeast Nodular and plaque KX434669; KX583727; KX583704
Fonsecaea pedrosoi CMRP1306 MA, Northeast Nodular, verrucous and plaque KX434670; KX583728; KX583705
Fonsecaea pedrosoi CMRP1308 MA, Northeast Plaque KX434671; KX583729; KX583706
Fonsecaea pedrosoi CMRP1309 MA, Northeast Scarring and plaque KX434672; KX583730; KX583707
Fonsecaea pedrosoi CMRP1310 MA, Northeast Plaque KX434673
Fonsecaea pedrosoi CMRP1311 MA, Northeast Plaque KX434674; KX583731
Fonsecaea pedrosoi CMRP1313 MA, Northeast Plaque KX434675; KX583732
Fonsecaea pedrosoi CMRP1314 MA, Northeast NI KX434676; KX583733
Fonsecaea pedrosoi CMRP1315 MA, Northeast Nodular, tumoral and plaque KX434677; KX583734
Fonsecaea pedrosoi CMRP1316 MA, Northeast Plaque KX434678
Fonsecaea pedrosoi CMRP1318 MA, Northeast NI KX434679
Fonsecaea pedrosoi IAL 3991 BA, Northeast Verrucous KU881737
Fonsecaea pedrosoi IAL 3997 BA, Northeast Verrucous KU881741
Fonsecaea pedrosoi IAL 3996 BA, Northeast Verrucous KU881745
Fonsecaea pedrosoi CMRP1331 PA, North Nodular KX434680
Fonsecaea pedrosoi CMRP1332 PA, North Nodular KX434681; KX583735
Fonsecaea pedrosoi CMRP1333 PA, North Nodular KX434682
Fonsecaea pedrosoi CMRP1334 PA, North Nodular KX434683; KX583736
Fonsecaea pedrosoi CMRP1337 PA, North Nodular KX434684
Fonsecaea pedrosoi CMRP1338 PA, North Nodular KX434685; KX583737
Fonsecaea pedrosoi CMRP1339 PA, North Nodular KX434686; KX583738
Fonsecaea pedrosoi CMRP1340 PA, North Nodular KX434687; KX583739
Fonsecaea pedrosoi CMRP1341 PA, North Nodular KX434688; KX583752
Fonsecaea pedrosoi CMRP1344 PA, North Nodular KX434689; KX583740
Fonsecaea pedrosoi CMRP1345 PA, North Nodular KX434690
Fonsecaea pedrosoi CMRP1346 PA, North Nodular KX434691; KX583741
Fonsecaea pedrosoi CMRP1347 PA, North Nodular KX434692
Fonsecaea pedrosoi CMRP1348 PA, North Nodular KX434693; KX583742
Fonsecaea pedrosoi CMRP1349 PA, North Nodular KX434694
Fonsecaea pedrosoi CMRP1350 PA, North Nodular KX434695; KX583743
Fonsecaea pedrosoi CMRP1351 PA, North Plaque KX434696; KX583744
Fonsecaea pedrosoi CMRP1352 PA, North Nodular KX434697; KX583745
Fonsecaea pedrosoi CMRP1353 PA, North Nodular KX434698; KX583746
Fonsecaea pedrosoi CMRP1354 PA, North Nodular KX434699
Fonsecaea pedrosoi CMRP1355 PA, North Nodular KX434700; KX583747
Fonsecaea pedrosoi CMRP1356 PA, North Nodular KX434701
Fonsecaea pedrosoi CMRP1357 PA, North Nodular KX434702; KX583748
Name Strain number Geograph/ Brazil Chromoblastomycose lesions ITS; BT2; CDC42; LSU
Fonsecaea pedrosoi CMRP1361 PA, North Nodular KX434703
Fonsecaea pedrosoi IAL 3998 RO, North Nodular and tumoral KU881736
Fonsecaea pedrosoi IAL 4001 RO, North Verrucous KU881744
Fonsecaea pedrosoi IAL 4005 RO, North Polymorphic lesions KU892413
(Continued )
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progressed with 3 years of evolution; muriform cells were observed in tissue (Fig 6A and 6B).
Patient was treated orally with itraconazole (200 mg/day), leading to improvement of the
lesions during treatment within three months. Patient abandoned treatment after 12 months
and returned in 2011 with recurred lesions spreading throughout the lower limb, following a
lymphatic path, with secondary infections, presenting verrucous type injuries, ulceration and
crusting at the surface. The fungus was re-isolated from the recurred lesions. The patient was
treated using itraconazole (200 mg/day) combined with cryosurgery.
Notes: The strain clustered with members of Chaetothyriales variously classified in Cyphel-
lophora or Phialophora. Several of these have been reported from mild infections of human
skin but without presence of muriform cells. Cyphellophora ludoviensis is the only species in
the ‘europaea-clade’ (Cyphellophoraceae) where muriform cells were observed in the lesions,
Table 1. (Continued)
Fonsecaea pedrosoi IAL 4007 RO, North Verrucous KU892414
Fonsecaea pedrosoi CMRP1336 MG, Southeast NI KX434709
Fonsecaea pedrosoi CMRP1362 MS, Southeast NI KX434704
Fonsecaea pedrosoi CMRP1363 MS, Southeast NI KX434705
Fonsecaea pedrosoi CMRP1364 MS, Southeast NI KX434706
Fonsecaea pedrosoi CMRP1365 MS, Southeast NI KX434707
Fonsecaea pedrosoi IAL 3993 MG, Southeast Nodular and tumoral KU881738
Fonsecaea pedrosoi CMRP1372 PR, South Nodular and verrucous KX434710
Fonsecaea pedrosoi CMRP1384 PR, South Nodular and verrucous KX434717
Fonsecaea pedrosoi CMRP1373 PR, South Scarring KX434711
Fonsecaea pedrosoi CMRP1374 PR, South Scarring and verrucous KX434712
Fonsecaea pedrosoi CMRP1375 PR, South Nodular and verrucous KX434713
Fonsecaea pedrosoi CMRP1376 PR, South Verrucous KX434714
Fonsecaea pedrosoi CBS 102245 PR, South Scarring and verrucous AY366918; EU938562
Fonsecaea pedrosoi CBS 102247 PR, South NI AY366919; EU938566
Fonsecaea pedrosoi CMRP1377 PR, South Verrucous KX434715
Fonsecaea pedrosoi CMRP1378 PR, South Plaque KX434720
Fonsecaea pedrosoi CMRP1379 PR, South Polymorphic lesions KX434721
Fonsecaea pedrosoi CMRP1380 PR, South Nodular and tumoral KX434716
Fonsecaea pedrosoi CMRP1381 PR, South Nodular and tumoral KX434718
Fonsecaea pedrosoi CMRP1382 PR, South NI KX434719
Fonsecaea pedrosoi CMRP1370 RS, South NI KX434708
Fonsecaea pedrosoi IAL 4000 NI Polymorphic lesions KU881743
Fonsecaea pedrosoi IAL 4006 NI Verrucous KU892409
Fonsecaea pedrosoi IAL 4002 NI Verrucous KU892410
Fonsecaea pugnacius CBS 139214 MA, Northeast Plaque and disseminated to brain KR706553; KR706547; KR706551
Cyphellophora ludoviensis sp. nov. CMRP1317 MA, Northeast Nodular and plaque KX434722; KX583749; -; KX583708
Rhinocladiella tropicalis sp. nov. CMRP1287 MA, Northeast Polymorphic lesions KX434723; KX583750; -; KX583709
Rhinocladiella tropicalis CMRP1307 MA, Northeast Plaque KX434724; KX583751; -; KX583710
Rhinocladiella tropicalis IMT776 SP, South NI KU854928
CMRP, Microbial Collections of Parana´ Network- TAXon line; CBS, CBS-KNAW Fungal Biodiversity Centre, Utrecht, The Netherlands; IMT, Tropical
Medicine Institute, SP, Brazil; IAL, Culture Collection of Adolfo Lutz Institute. BT2, partial beta-tubulin gene; ITS, internal transcribed spacer regions of the
rDNA and intervening 5.8S nuclear ribosomal DNA (nrDNA); CDC42, partial cell division cycle gene. Brazil Sates: BA. Bahia; MA. Maranhão; MG. Minas
Gerais; MS. Mato Grosso do Sul; PA. Para; RO. Rondoˆnia; PR. Parana´; RS. Rio Grande do Sul; SP. São Paulo; NI. not informed, patients in treatment at
SP.
doi:10.1371/journal.pntd.0005102.t001
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Fig 2. Multilocus tree of Cyphellophora based on ITS and partial BT2 sequences. Constructed with maximum
likelihood implemented in MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches.
Novel Agents of Human Chromoblastomycosis
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and is distant from remaining species causing this disease, as well as from the generic type of
Phialophora, P. verrucosa.
Rhinocladiella tropicalis C.M.P.S. Azevedo, R.R. Gomes, V.A. Vicente & de Hoog, sp. nov.
– MycoBank MB 817306 (Figs 3 and 7).
Etymology: Named after its occurrence in tropical South America.
Holotype: Maranhão State, Brazil, from skin lesion of human patient, dried holotype UPCB
85593 at Department of Botany Herbarium at Federal University of Parana´ (UPCB); type
strain CMRP1287 = LMICRO326 = CBM17. Additional material examined listed in Table 1.
Description of CMRP1287 after two weeks incubation on MEA at 28˚C: Colonies growing
moderate rapidly, velvety, elevated, olivaceus black with dark reverse. Mycelium partly
immersed but mainly aerial, composed of branched hyphae which are pale brown, occasionally
reddish brown, 1.5–2.5 μm wide, regularly septate every 7–18 μm, with integrated conidiogen-
ous cells which are somewhat differentiated from vegetative hyphae. Conidiophores erect,
straight, thick-walled, brown to dark brown, up to 19 μm high, bearing small, pigmented den-
ticles on which conidia are produced in sympodial order. Conidiogenous cells terminal or lat-
eral, often becoming intercalary, cylindrical in the apical part with numerous flat scars.
Conidia one-celled, hyaline to pale brown, ellipsoidal to clavate, 2.5−5.0 × 1.5−2.5 μm; scars
slightly prominent, approx. 0.4 μm diam, pigmented. Conidia usually 1-septate, 5−8 × 1.5
−3.0 μm. Budding cells developing from single conidia may be present. Teleomorph unknown.
Cardinal temperatures: minimum 18˚C, optimum 27˚C, maximum 37˚C, with residual growth
at 15˚C.
Case reports: Patient infected by R. tropicalis CMRP1287 was a 65-year-old caucasian male
from Pinheiro, Maranhão, Brazil, diagnosed in 2004 with lower limb injuries showing poly-
morphic lesions with plaques and nodular and cicatrized lesions. Muriform cells were
observed in tissue (Fig 6C and 6D). The infection evolved during a 6-year period. Treatment
was started with itraconazole (200 mg/day), irregularly until 2012; subsequently regular treat-
ment was installed but with low response. From then onwards additional cryosurgery with liq-
uid nitrogen was applied once a week. After 4 years of therapy still some lesions with a fibrotic
aspect and with few murifom cells were observed. Patient infected by R. tropicalis CMRP1307
strain was a 78-year-old afrodescendant male, from Icatu, Maranhão, Brazil, diagnosed in
2002 with lower limb injuries showing polymorphic lesions with plaques and infiltration and
muriform cells in tissue (Fig 6E and 6F). The diseased showed moderate development over a
3-year period of evolution. Patient was treated with oral itraconazole (200 mg/day), initiated in
2010. Some treatment interruptions occurred because of the distance to the patient’s living
place and the low response to itraconazole, with worsening of the symptoms.
Both patients are still under treatment in 2016. The patient infected by R. tropicalis
CMRP1287 is currently treated using itraconazole (200 mg/day) combined with cryosurgery
and the patient infected by R. tropicalis CMRP1307 uses the antifungals itraconazole (400 mg/
day) and terbinafin (250 mg twice daily) in combination.
During our studies we noticed strain IMT766, isolated in 1970 from a case of chromoblas-
tomycosis and deposited in the Institute of Tropical Medicine, São Paulo, Brazil, and supple-
mentary material from a patient infected by strain CBS 132913, a 63-year-old male
construction worker from Venezuela with an asymptomatic and localized skin lesion of the
hand with a scaly, crusted, dull-red appearance, friable with hemorrhagic dots [19].
Cladophialophora yegresii and C. carrionii comprised the outgroup. Novel species causing chromoblastomycosis are
indicated with red branches. Type strain in bold.
doi:10.1371/journal.pntd.0005102.g002
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The response to treatment has been evaluated by clinical, mycological and histopathological
criteria. A complete clinical response is being accompanied assuming for cure criteria after
Fig 3. Multilocus tree of Rhinocladiella based on ITS and partial BT2 sequences. Constructed with maximum likelihood implemented in
MEGA 7. Bootstrap values of >80% from 100 resampled data sets are shown with branches. Cladophialophora yegresii and C. carrionii
comprised the outgroup. Novel species causing chromoblastomycosis are indicated with red branches. Type strain in bold.
doi:10.1371/journal.pntd.0005102.g003
Novel Agents of Human Chromoblastomycosis
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two years follow up without recurrence, with complete healing of the lesions and disappear-
ance of itching and local pain. The patients must also be monitored by three to four consecu-
tive biopsies to access the mycological and histopathological criteria of cure. A mycological
response will be achieved after no observation of fungal elements upon direct examination and
failure to isolate the causal agent from tissue fragments.
Notes: With LSU rDNA the novel species clusters close to Rhinocladiella aquaspersa and R.
phaeophora in the ‘jeanselmei clade’ in Herpotrichiellaceae (Fig 1). Members of this cluster are
morphologically outstanding by stiff, erect conidiophores packed with sympodial, non-catenate
conidia. With ITS (Fig 3), distances of 5.1% were noted between R. tropicalis and R. aquaspersa,
and 5.4% with R. phaeophora (Table 2), underlining that a complex of sibling species is concerned.
Discussion
In this study, we describe two novel species of black fungi causing chromoblastomycosis infec-
tions. Among a set of 123 strains from cases of this disease, representatives of three genera
were recognized, i.e. Fonsecaea, Rhinocladiella, and Cyphellophora. No member of Cladophialo-
phora was encountered, which is explained by climatic conditions, as C. carrionii is prevalent
in arid environmental conditions. In Brazil C. carrionii is rarely reported [24, 25]. The preva-
lent species in humid tropical climates of South America remains Fonsecaea pedrosoi, followed
by F. monophora [2], while the latter species is predominant in southern China [26]. All four
species of genus Fonsecaea related to chromoblastomycosis were found in the Brazilian
endemic area. Judging from literature data, F. pedrosoi and F. nubica seem to be pathogens
that are strictly associated with chromoblastomycosis, while F. monophora and F. pugnacius
show some degree of neurotropism eventually leading to dissemination to the brain and other
organs [14, 27].
Table 2. Estimates of Evolutionary Divergence of Rhinocladiella tropicalis. Distance R. aquaspersa to R. phaeophora ITS (4.5) and BT2 (5.6); Lengths
of alignments of ITS: 548 bp and BT2: 349 bp. Analyses were conducted using the Kimura 2-parameter model. All ambiguous positions were removed for
each sequence pair. Evolutionary analyses were conducted in MEGA 7.
Locus R. aquaspersa R. phaeophora R. fasciculata R. atrovirens R. mackenzie R. anceps R. basitona R. similis
ITS 5.1 5.4 11.4 18.6 19.7 20.4 21.7 22.0
BT2 9.7 10.7 —— —— —— —— 34.8 36.5
doi:10.1371/journal.pntd.0005102.t002
Fig 4. Cardinal temperatures of strains described. (A) Cyphellophora ludoviensis with optimal growth temperature at 30˚C and maximum at 37˚C. (B)
Rhinocladiella tropicalis with optimal development at 27˚C and maximum at 37˚C.
doi:10.1371/journal.pntd.0005102.g004
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The genus Cyphellophora is characterized by phialides producing sickle-shaped, septate
conidia [28]. The group clusters with some phialidic species with small, one-celled conidia.
Although the generic type species of Phialophora, P. verrucosa clusters in the ‘carrionii-clade’
distant from Cyphellophora, Feng et al. [22] classified them in Phialophora on morphological
criteria. Later Re´blova´ et al. [29] took phylogeny as the leading principle and reclassified all
species of the ‘europaea-clade’ in Cyphellophora, the only genus of the newly established family
Fig 5. Cyphellophora ludoviensis microscopic morphology. (A) colonies on SGA; (B-E) hyphae with
chlamydospores and lateral extensions; (F) anastomosis; (G-H) spirally twisted hyphae; (I) poorly differentiated
phialide producing conidia; (J-P) chlamydospores and conidia. Scale bars 10 μm.
doi:10.1371/journal.pntd.0005102.g005
Novel Agents of Human Chromoblastomycosis
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Cyphellophoraceae. Since the taxonomy of Chaetothyriales is in a flux with numerous species
to be added, we judge establishment of categories above the species level premature. Currently,
phylogenetic data do not match with any other criterion established thus far in Chaetothyriales
[21], and therefore phylogenetic genera and families in this order inevitably will remain
counterintuitive.
Fig 6. Clinical case pictures. (A, B) Nodular and verrucous lesions and muriform cells from skin tissue biopsy of
arm lesion caused by Cyphellophora ludoviensis (CMRP1317); (C-E) polymorphic infiltrative plaque lesions caused
by different strains of Rhinocladiella tropicalis affecting the legs, (C) with nodular and cicatricial and (E) verrucous
lesions; (D-F) muriform cells from skin tissue biopsy of lesions caused by R. tropicalis strains CMRP1287 and
CMRP1307, respectively.
doi:10.1371/journal.pntd.0005102.g006
Novel Agents of Human Chromoblastomycosis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005102 November 28, 2016 13 / 20
Cyphellophora ludoviensis is not effective to produce conidia on common mycological
media; it was placed in the genus based on DNA sequence analyses. Members of the genus
Cyphellophora colonize different habitats including, in addition to humans, plant debris, ant
nests and abiotic substrates [22]. Our species is genetically close to C. capiguarae, described as
living in association with ants (Atta capiguara), and to C. oxyspora from decaying leaves [30,
31]. Other members of Cyphellophora originate from mild cutaneous infections in humans,
Fig 7. Rhinocladiella tropicalis, microscopic morphology. (A) Colonies on SGA; (B, C) twisted hyphae and
conidia; (D-G) conidiophores with conidia produced in sympodial order; (H-O) conidial apparatus with conidia. Scale
bars 10 μm.
doi:10.1371/journal.pntd.0005102.g007
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mostly from skin and nails [22]. Cyphellophora europaea in particular has been encountered
globally as an agent of mild skin disease and onychomycosis [31] and was noted co-occurring
with dermatophytes, mainly Trichophyton rubrum affecting the skin of diabetic patients [32].
Environmental strains of this species were found in indoor wet cells, such as bathrooms and
washing machines [33, 34]. Cyphellophora ludoviensis is the first species in the Cyphellophora-
ceae that had muriform cells in tissue and showed acanthosis rather than necrosis; on the basis
of these features the infection was classified as chromoblastomycosis.
The new species Rhinocladiella tropicalis is a cryptic species close to R. phaeophora and R.
aquaspersa. Rhinocladiella phaeophora was known from a single strain recovered from maize
field soil in Colombia [35]. It has recently been reported from a case of human chromoblastomy-
cosis, but the sequence of this strain was not available for comparison [36]. This report neverthe-
less suggests that all members of the cluster consistently are able to cause chromoblastomycosis
when inoculated into human skin. Rhinocladiella aquaspersa is a classical agent of chromoblasto-
mycosis, nearly all cases having been reported from the American continent [19], but the major-
ity of historical clinical cases have not been verified by sequence data. Strain CBS 132913 was
originally reported as R. aquaspersa but was found to be 100% identical with R. tropicalis. The
three species are phenotypically and clinically similar, but their sequence diversity interferes with
molecular recognition of R. aquaspersa as a single species. According to Chen et al. [37] the term
‘species complex’ could be applied used to indicate closely related species do not seem to differ
in clinically relevant parameters. The present rhinocladiella-like lineages have sufficient molecu-
lar distance to be recognized as species, but additional studies of antifungal susceptibility, clinical
course, virulence and physiology are needed to verify significance of distinction of the three
agents as individual species in hospital routine.
Chromoblastomycosis is clinically highly variable, with six different clinical types [8, 38].
Despite the polymorphic nature of lesions, common factor at the patient side is the absence of
necrosis and often even hyper-growth of dermal tissues, which distinguishes the disease from its
clinical counterpart, phaeohyphomycosis. At the fungal side, the invasive form is the muriform
cell, which is likely to be the cause of the growth-promoting dermal response. As such the dis-
ease is polyphyletic within the Chaetothyriales, but has not or extremely rarely been observed
outside this order. In both cases caused by these two new species here described it was encoun-
tered polymorphic lesions frequently related to clinical cases of chromoblastomycosis [8].
In the State of Maranhão, Brazil, five chaetothyrialean agents of chromoblastomycosis are
endemic. A potential source of infection has been suggested [39] to be the harvest of babassu
coconuts from a wild palm tree (Orbignya phalerata). A large part of the local rural population
is involved in the collection of nuts to extract babassu oil, an important component for local
and international beauty product manufacturers. Members of Chaetothyriales are indeed
enriched on babassu shell fragments, which are considered a risk factor for developing chro-
moblastomycosis after trauma sustained at work [39, 40]. A direct link between shells and
agents of the disease has however not unambiguously been established. In other Brazilian
regions the number of new cases of chromoblastomycosis is decreasing [8, 41, 42]. This is
thought to reflect changes in agricultural practices, the extensive use of agricultural antifungals,
especially azole derivatives, and the progressive mechanization of plantations resulting in a
reduction of the risk of occupational exposure [8, 43, 44].
Our results showed that C. ludoviensis and R. tropicalis had their optimal development at 30
and 27˚C, respectively, the maximum growth temperature of all strains analyzed being at
37˚C. The chronic nature of the infection corresponds with borderline survival of the fungus
in tissue. Epidermal temperatures are usual below 37˚C, allowing infection by fungi that barely
support this temperature. This agrees with the clinical observation that members of the
Novel Agents of Human Chromoblastomycosis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005102 November 28, 2016 15 / 20
Cyphellophoraceae (‘europaea-clade’), which have their maximum growth at 36˚C, cause only
mild, superficial infections, having a very low degree of invasive ability and virulence [22].
According to the World Health Organization (WHO) [45] the Neglected Tropical Diseases
include a series of endemic diseases that prevail in tropical or subtropical areas worldwide.
The prevalence of causative microbes is linked to poverty and disadvantage. However, fungal
diseases were still not included in this list, except mycetoma, another implantation mycosis
[46]. Chromoblastomycosis has been reported in the literature as an overlooked disease [11].
Its global burden is comparable to or greater than that of mycetoma. Considering to its global
distribution, its impact on the impoverished, and its refractoriness, it also should be consid-
ered a true neglected disease as defined by WHO.
Materials and methods
Strains studied
Strains analyzed comprised 123 clinical isolates (Table 1) from different cases and several
endemic areas in Brazil, with viable cultures for molecular epidemiology studies and with detailed
registration data deposited in medical file systems of the institutions involved in this study. All
the clinical strains were deposited at Microbial Collections of Parana´ Network- TAXon line at
Federal University of Parana´, the register numbers, others nomenclature references and addi-
tional information were informed in the Table 1. The Holotype number was provided from
Department of Botany Herbarium at Federal University of Parana´ (UPCB), TAXon line collec-
tions network (http://taxonline.nerdweb.com.br/), register number at http://www.splink.org.br/.
This work was approved by the Research Ethics Committee-CEP-HUUFMA (University
Hospital of the Federal University of Maranhão), according to Brazilian Resolution -Approval
number: 1.276.342. All samples were anonymized. The set was supplemented with reference
strains from the Centraalbureau voor Schimmelcultures (CBS/KNAW) Fungal Biodiversity
Centre, Utrecht, Netherlands and the strain previously described as R. aquaspersa CBS 132913
was included in the phylogenetic analysis. Stock cultures were maintained in slants of 2% malt
extract agar (MEA) and oatmeal agar (OA) at 24˚C. For morphological studies, MEA and
potato dextrose agar (PDA) slide cultures were prepared and mounted in aniline blue.
Physiology
Cardinal growth temperatures were determined on 2% MEA. Plates were incubated in the dark
for 3 weeks at a 3–36˚C temperature range with intervals of 3˚C; growth was also recorded at
14, 37, 38, 39 and 40˚C. Growth rates per species were obtained by calculation of the average
growth of all isolates proven to belong to that species, including the respective standard devia-
tions. Results were plotted with temperature (˚C) versus colony diameter (mm) as parameters.
Optimum range (= average ± standard deviation) and maximum growth temperatures were
determined using the type strains of each species with three replicates averages of three mea-
surements were calculated. Different temperatures were tested, at 28˚C was observed the largest
number of structures to Chyphellophora and it was used to describe the species morphology.
DNA extraction and amplification
DNA extraction and quality tests were performed using glass beads (Sigma G9143) according
to protocols described previously [23] and when it was required, the purification of DNA was
undertaken using the UltraClean™ Microbial DNA Kit (MO Bio, Carlsbad, CA, USA) accord-
ing to manufacturer’s instructions. Colonies were cultivated on Sabouraud’s glucose agar
(SGA).
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The partial large subunit of the nuclear ribosomal RNA gene (LSU) was amplified using
primers NL1 and LR5 [22] for phylogenetic assessment. Three gene regions were chosen for
species delimitation: rDNA Internal Transcribed Spacer (ITS), and the partial genes cell divi-
sion cycle gene (CDC42) and β-tubulin (BT2). ITS amplicons were generated with primers
V9G and LS266 [47, 48] and were sequenced with primers ITS1 and ITS4. CDC42 amplifica-
tion and sequencing was generated with cdc42w and cdc42f [49] and BT2 amplification and
sequencing was generated with Bt-2a and T2 [50]. PCR was performed in a 12.5 μL volume of
a reaction mixture containing 1× PCR buffer, 2.0 mM MgCl2, 25 μM dNTPs, 0.5 μM of each
forward and reverse primers, 1 U of BioTaq DNA polymerase, and 10 ng of genomic DNA.
Amplification was performed in an ABI PRISM 2720 (Applied Biosystems, Foster City,
USA) thermocycler as follows: 95˚C for 4 min, followed by 35 cycles consisting of 95˚C for
45s, 52˚C for 30s and 72˚C for 2 min, and a delay at 72˚C for 7 min. Annealing temperatures
were changed to 52˚C, 55˚C and 58˚C for ITS, CDC42 and BT2 respectively. Amplicons were
cleaned with Exonuclease I and Shrimp Alkaline Phosphatase (SAP) according to manufactur-
er’s instructions. Amplicons were sequenced with a BigDye Terminator Cycle Sequencing Kit
v. 3.1 (Applied Biosystems, Foster City, CA, USA) according to the manufacturer’s instruc-
tions, reactions were purified with Sephadex G-50 fine (GE Healthcare Bio-Sciences, Uppsala,
Sweden) and sequences were analysed on an ABI Prism 3700 DNA Sequencer (Perkin-Elmer,
Norwalk, Foster City, CA, USA).
Phylogenetic analysis
Consensus sequences of the ITS region, BT2, CDC42, and the LSU were visually inspected
using MEGA v.7 software [51]. The alignment of obtained sequences was performed using the
online MAFFT interface [52]. The genes ITS, CDC42 and BT2 were first analyzed separately
and for analysis of multilocus (S1 Fig). We did the LSU analyses to assess the phylogenetic
position of the species analyzed in this study. The phylogenetic analyses of the small subunit
(SSU) and LSU groups previously recognized in the Herpotrichiellaceae by de Hoog et al. [21],
Feng et al. [22] and Vicente et al. [23] were taken as a basis for clade delimitation. Trees were
constructed with 100 bootstrap replicates using the Maximum Likelihood Implemented in
Mega v. 7 software [51], with the best evolutionary model to this dataset. Conflicts were esti-
mated using the partition homogeneity test available in PAUP v. 4.Ob10 [53]. To elucidated
and explore a more detailed the clustering unnamed species, their sequences were compared
to those deposited at GenBank and the CBS-KNAW sequence data sets.
Supporting Information
S1 Fig. Multilocus tree of Fonsecaea and Cladophialophora based on confidently aligned
ITS and partial BT2 and CDC42 sequences. Constructed with maximum likelihood imple-
mented in MEGA 7.0. Bootstrap values of<80% from 1,000 resampled data sets are shown
with branches. Cladophialophora yegresii (CBS 114406, CBS 114407 and CBS 114405) and C.
carrionii (CBS 161.54, CBS 406.96, CBS 165.54 and CBS 108.97) comprised the outgroup. Fon-
secaea species causing chromoblastomycosis are indicated in red. Type strain in bold.
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